0001501756-13-000002.txt : 20131126 0001501756-13-000002.hdr.sgml : 20131126 20131126104914 ACCESSION NUMBER: 0001501756-13-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131126 DATE AS OF CHANGE: 20131126 EFFECTIVENESS DATE: 20131126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avalanche Biotechnologies, Inc. CENTRAL INDEX KEY: 0001501756 IRS NUMBER: 205258327 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-207011 FILM NUMBER: 131242802 BUSINESS ADDRESS: STREET 1: 2749 CAROLINA AVENUE CITY: REDWOOD CITY STATE: CA ZIP: 94061 BUSINESS PHONE: 415-203-1722 MAIL ADDRESS: STREET 1: 2749 CAROLINA AVENUE CITY: REDWOOD CITY STATE: CA ZIP: 94061 D 1 primary_doc.xml X0707 D LIVE 0001501756 Avalanche Biotechnologies, Inc. 665 Third Street, Suite 250 San Francisco CA CALIFORNIA 94107 650-735-1324 DELAWARE None None Corporation true Thomas W. Chalberg c/o Avalanche Biotechnologies, Inc. 665 Third Street, Suite 250 San Francisco CA CALIFORNIA 94107 Executive Officer Director Mark S. Blumenkranz c/o Avalanche Biotechnologies, Inc. 665 Third Street, Suite 250 San Francisco CA CALIFORNIA 94107 Director Steven D. Schwarz c/o Avalanche Biotechnologies, Inc. 665 Third Street, Suite 250 San Francisco CA CALIFORNIA 94107 Director Biotechnology Decline to Disclose 06b false 2010-09-07 false true false 0 6138277 5653890 484387 false 16 0 0 0 false Avalanche Biotechnologies, Inc. /s/ Thomas W. Chalberg Thomas W. Chalberg, Ph.D. President & Chief Executive Officer 2013-11-22